NCT02650310

Brief Summary

The embryo transfer implies transportation from the incubator where they have been at 37 ° C, to the transfer catheter inside a laminar flow hood whose working surface is also maintained at 37 ° C. . From the laboratory to the operating room the embryo is exposed to a temperature drop, and consequently thermal stress occurs, which may compromise its future viability. The aim of this study is to assess the possible improvement in the clinical results when the embryos are transported in a stable device to avoid the drop in temperature throughout the transfer process. With the use of this thermosetting device heated to 37 ° C, researchers expect a 15% increase in pregnancy rates.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
352

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 8, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

August 9, 2019

Status Verified

August 1, 2019

Enrollment Period

3.9 years

First QC Date

September 28, 2015

Last Update Submit

August 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ongoing Pregnancy rate

    Achieving an ongoing pregnancy after embryo transfer

    Ongoing pregnancy until 28th week of gestation

Secondary Outcomes (2)

  • Miscarriage rate

    Loss of pregnancy up to 12 weeks of gestation

  • Implantation rate

    Embryo implantation after 6-7 weeks of gestation

Study Arms (2)

Conventional transfer

NO INTERVENTION

This arm is the control group (conventional embryo transfer protocol) where there is no intervention.

Thermostable device transfer

EXPERIMENTAL

This arm is the study group: embryo transfer protocol using a new thermostable device.

Device: Thermostable device

Interventions

Investigators place the catheter with the loaded embryos into a plastic device at 37ºC in order to maintain the temperature

Thermostable device transfer

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Cryo-transfer cycles: transfer of embryos vitrified in previous cycles receiving donated eggs inseminated with either conjugal or donated sperm from Instituto Bernabeu bank.

You may not qualify if:

  • Fresh cycles: transfer of fresh embryos (coming from donated or own eggs), and cryo-transfer cycles from vitrified embryos coming from own oocytes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Bernabeu

Alicante, 03016, Spain

RECRUITING

Central Study Contacts

Jorge Ten Morro, Ph.D.

CONTACT

Jorge Ten Morro, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Gynecologist; M D; Ph D

Study Record Dates

First Submitted

September 28, 2015

First Posted

January 8, 2016

Study Start

April 1, 2015

Primary Completion

March 1, 2019

Study Completion

December 1, 2019

Last Updated

August 9, 2019

Record last verified: 2019-08

Locations